SPV

Recent news mentioning SPV

• 2026-10-07 — SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies

Appears alongside

• SRX
• CERO
• CER

Browse the full archive →